Welcome to the Montana Chapter of the American College of Cardiology
Welcome to the Montana Chapter of the American College of Cardiology
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- ACC CardiaCast: Spotlight on Behavioral Health, Thrombosis and FertilityIn this episode, Gregory Piazza, MD, FACC, Elvira Grandone, MD, PhD, and Abbey R. Kruper, PsyD, ABPP walk through the clinical and emotional challenges of the link between thrombosis and fertility.
- CMS Rule Eliminates Faxes For Claims TransactionsThe Centers for Medicare and Medicaid Services (CMS) has finalized a rule establishing national standards for the secure electronic exchange of health care claims attachments and electronic signatures. These changes are part of CMS' ongoing efforts to replace manual processes such as faxing and mailing with standardized electronic transactions using X12N standards and Health Level […]
- Revolutionizing Vascular Medicine: The Transformative Role of Artificial Intelligence in Diagnosis, Management, and OutcomesArtificial intelligence (AI) is rapidly reshaping how clinicians approach vascular disease, offering sophisticated tools that enhance diagnostic accuracy, enable earlier disease detection, and improve risk stratification across the spectrum of peripheral artery disease (PAD), pulmonary embolism (PE), carotid artery disease, and aortic disease.
- Editors' Corner | Proven, Practical, Patient First: Turning Research Into ResultsThis issue brings together a set of stories united by a central theme familiar to every cardiologist: how high‑quality evidence becomes high‑value care. From prevention in childhood to advanced interventions for complex disease, each story in these pages reflects a different point along the continuum of heart health – yet all focus on turning research […]
- Cover Story | Renal Denervation: From Controversy to Comeback in Hypertension CareFew therapies in cardiovascular medicine have traveled a path as turbulent as renal denervation. Once hailed as a breakthrough for uncontrolled hypertension, the field was abruptly shaken by neutral findings from SYMPLICITY HTN-3.
